Other International projects

ANALYSIS OF THE CHROMATIN ACCESIBILITY LANDSCAPE AND REGULATORY NETWORKS OF IgM MONOCLONAL GAMMOPATHIES: TOWARDS A BETTER UNDERSTANDING OF PROGRESSION MECHANISMS

PI: FERNANDEZ DE LARREA RODRIGUEZ, CARLOS JO
Funding: International Waldenstrom's Macroglobulinemia Foundation
Beneficiary organization: FRCB-IDIBAPS
Reference: IWMF_SMI_22_01
Amount: 76,805.16 €
Duration: 26/10/2022 to 25/04/2024

TIC Genetics - 1/7-Collaborative Genomics Studies of Tourette Disorder

PI: MORER LIÑAN, ASTRID
Funding: ACADEMISCH ZIEKENHUIS GRONINGEN
Beneficiary organization: FRCB-IDIBAPS
Reference: 671128
Amount: 49,956.31 €
Duration: 15/06/2018 to 30/04/2024

Intra-tumoral heterogeneity and clinical impact in HER2-positive and triple-negative early breast cancer

PI: PRAT APARICIO, ALEIX
Funding: Breast Cancer Research Foundation - BCRF
Beneficiary organization: FRCB-IDIBAPS
Reference: 988310
Amount: 224,596 €
Duration: 01/10/2022 to 30/09/2024

Genomic-Based Biomarkers for Predicting Ribociclib Response in Early-Stage Hormone Receptor-Positive and HER2-Negative Breast Cancer (RIBOLARIS-PREDICT)

PI: PRAT APARICIO, ALEIX
Funding: Breast Cancer Research Foundation - BCRF
Beneficiary organization: FRCB-IDIBAPS
Reference: BCRF_AAP_01
Amount: 209,086.18 €
Duration: 01/10/2023 to 30/09/2024

In-vitro activity of CD5CAR-NK cells against moulds causing invasive fungal disease

PI: PUERTA ALCALDE, PEDRO
Funding: European Society of Clinical Microbiolog and Infectious Diseases (ESCMID)
Beneficiary organization: FRCB-IDIBAPS
Reference: ESCMID_22_1
Amount: 19,998 €
Duration: 01/04/2023 to 30/09/2024

Efecto del Tratamiento agudo con corticoides endovenosos en las partes blandas en fracturas de pilón tibial, retropié y mediopié en relación con tiempo desde ingreso hasta tratamiento quirúrgico

PI: GARCIA ELVIRA, RUBEN
Funding: AO Foundation AO Global Networks
Beneficiary organization: FRCB-IDIBAPS
Reference: 2021-AOTESASPAIN_003
Amount: 7,254.75 €
Duration: 15/01/2022 to 30/10/2024

Multicentre assessment of nasal swabbing approach: alpha-syn RT QuIC assay diagnostic performance inolfactory mucosa and cerebrospinal fluid in patients with prodromal PD, PD or PD with neurocognitive impairment

PI: MARTI DOMENECH, MARIA JOSEFA
Funding: UNIVERSITA DEGLI STUDI DI VERONA
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-021307
Amount: 100,322.37 €
Duration: 01/04/2022 to 30/11/2024

Identifying New Therapeutic Targets in Obesity-Driven Liver Cancer

PI: FERNANDEZ LOBATO, MERCEDES
Funding: INSTITUT RECERCA BIOMEDICA BARCELONA (IRB)
Beneficiary organization: FRCB-IDIBAPS
Reference: 1766
Amount: 136,893 €
Duration: 01/01/2021 to 31/12/2024

Deciphering the mechanism underlying ECP-induced immunomodulation in kidney transplantation

PI: ROVIRA JUAREZ, JORDI
Funding: European Society for Organ Transplantation
Beneficiary organization: FRCB-IDIBAPS
Reference: ESOT_ECP_23_01
Amount: 50,000 €
Duration: 01/01/2024 to 31/12/2024

Fetal doppler for antenatal risk stratification.

PI: BIJNENS, BART
Funding: AGA KHAN UNIVERSITY
Beneficiary organization: FRCB-IDIBAPS
Reference: INV-021528
Amount: 566,436 €
Duration: 01/01/2021 to 31/12/2024

Phospho-proteome analysis of PBMCs in LRRK2 mutations carriers: expansion & validation of findings of the Barcelona LRRK2 Biorepository

PI: FERNANDEZ SANTIAGO, RUBEN
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-000858
Amount: 77,928.07 €
Duration: 01/08/2021 to 31/12/2024

PPMI - Parkinson's Progression Markers Initiative (PPMI) study

PI: ALDECOA ANSORREGUI, IBAN
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-024484
Amount: 52,683.78 €
Duration: 01/01/2021 to 31/12/2024

What works and why? Eye movement desensitization and reprocessing a potential treatment for substance use disorders

PI: MIQUEL DE MONTAGUT, LAIA
Funding: EMDR Foundation Eye Movement Desensitization & reprocess
Beneficiary organization: FRCB-IDIBAPS
Reference: 2022-02
Amount: 9,000 €
Duration: 01/04/2023 to 31/03/2025

Effectivenessof an EMDR intervention for the prevention of post-traumatic symptoms in perinatal loss

PI: TORRES GIMENEZ, ANNA
Funding: EMDR Foundation Eye Movement Desensitization & reprocess
Beneficiary organization: FRCB-IDIBAPS
Reference: 2022-03
Amount: 7,500 €
Duration: 01/04/2023 to 31/03/2025

HeBA - Barcelona 2022 PPMI Healthy Brain Aging Initiative

PI: MARTI DOMENECH, MARIA JOSEFA
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-022187
Amount: 968,050.79 €
Duration: 31/05/2022 to 30/05/2025

Dual CD19-CART approaches to counteract antigen escape and tumor microenvironment immune suppression in FL

PI: PEREZ GALAN, PATRICIA
Funding: International Follicular Lymphoma Challenge
Beneficiary organization: FRCB-IDIBAPS
Reference: MILKEN_FLF_22_01
Amount: 385,335.7 €
Duration: 01/12/2022 to 30/06/2025

Effects of circulating extracellular vesicles on pancreatic islets during obesity

PI: SERVITJA DUQUE, JOAN MARC
Funding: EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES
Beneficiary organization: FRCB-IDIBAPS
Reference: EFSD/BOEHR_22_01
Amount: 100,000 €
Duration: 09/01/2023 to 08/07/2025

MOLECULAR MEASURABLE RESIDUAL DISEASE (MRD) MONITORING BY HIGH-THROUGHPUT TECHNIQUES IN PATIENTS TREATED WITH CART19 THERAPY

PI: LOPEZ GUERRA, MONICA
Funding: Thermo fisher scientific inc.
Beneficiary organization: FRCB-IDIBAPS
Reference: THERMOONCOCRG_22_01
Amount: 186,393.29 €
Duration: 28/06/2023 to 31/08/2025

RIBOLARIS-PREDICT - Genomic-Based Biomarkers for Predicting Ribociclib Response in Early-Stage Hormone Receptor-Positive and HER2-Negative Breast Cancer (RIBOLARIS-PREDICT)

PI: PRAT APARICIO, ALEIX
Funding: Breast Cancer Research Foundation - BCRF
Beneficiary organization: FRCB-IDIBAPS
Reference: BCRF_AAP_24
Amount: 200,213.66 €
Duration: 01/10/2024 to 30/09/2025

Novel biomarkers related to sleep-wake alterations in Alzheimer's disease

PI: FALGAS MARTINEZ, NEUS
Funding: Alzheimer's Association
Beneficiary organization: FRCB-IDIBAPS
Reference: AACSF-21-723056
Amount: 151,178.86 €
Duration: 01/11/2021 to 31/10/2025

Molecular dissection of exosome-mediated bis(monocylglycero)phosphate release in Parkinson's disease-related LRRK2 dysfunction.

PI: FERNANDEZ SANTIAGO, RUBEN
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-023914
Amount: 10,582 €
Duration: 01/11/2023 to 31/10/2025

Early detection of perianal fistulizing disease- Pathophysiology and Imaging

PI: SALAS MARTINEZ, MARIA AZUCENA
Funding: THE LEONA M & HARRY B HELMSLEY CHARITABLE TRUST
Beneficiary organization: FRCB-IDIBAPS
Reference: 2008-04050
Amount: 1,745,753 €
Duration: 25/11/2019 to 24/11/2025

HUNTER: Hepatocellular Carcinoma Expediter Network

PI: LLOVET BAYER, JOSEP MARIA
Funding: Newcastle University Accounts Payable
Beneficiary organization: FRCB-IDIBAPS
Reference: AA_17_03
Duration: 01/11/2018 to 30/11/2025

Psoriasis, a metabolic dysregulation of the innate immune system? Targeting ZEB1 in macrophages as a new therapeutic approach to psoriasis

PI: POSTIGO ANGON, ANTONIO ANDRES
Funding: LEO FOUNDATION
Beneficiary organization: FRCB-IDIBAPS
Reference: LEO_19_01
Amount: 491,478 €
Duration: 01/03/2020 to 31/12/2025

Estudio comparativo biomecánico de dos métodos de osteosíntesis para fracturas de meseta tibial Schatzker tipo I

PI: RENAU CERRILLO, MARINA
Funding: AO Foundation AO Global Networks
Beneficiary organization: FRCB-IDIBAPS
Reference: AOTRAUMA_21_01
Amount: 7,221.89 €
Duration: 31/12/2021 to 31/12/2025

Deciphering the molecular signatures of gestational food cravings as drivers of eating disorders in the offspring

PI: HADDAD TOVOLLI, ROBERTA
Funding: Brain and Behaviour Research Foundation
Beneficiary organization: FRCB-IDIBAPS
Reference: BBRF_YI_23
Amount: 64,218 €
Duration: 15/01/2024 to 14/01/2026

A new target for the treatment of acute and chronic itch

PI: Gasull Casanova, Xavier
Funding: LEO FOUNDATION
Beneficiary organization: FRCB-IDIBAPS
Reference: LF-OC-22-001114
Amount: 351,488.65 €
Duration: 01/02/2023 to 31/01/2026

Type 2 inflammation and olfactory loss in chronic rhinosinusitis with nasal polyps: Role of Mepolizumab in olfactory cell neurogenesis

PI: MULLOL MIRET, JOAQUIM
Funding: Glaxosmithkline Research & Development Limited
Beneficiary organization: FRCB-IDIBAPS
Reference: 14859
Amount: 389,318.8 €
Duration: 01/09/2023 to 14/03/2026

Preclinical evaluation of Lilly LRRK2 inhibitors for Parkinson's disease using phosphoproteomic analysis

PI: EZQUERRA TRABALON, MARIO ANTONIO
Funding: LILLY, SAU
Beneficiary organization: FRCB-IDIBAPS
Reference: LILLY_RAP_23_01
Amount: 242,258.79 €
Duration: 19/03/2024 to 18/03/2026

Dissecting the role of the 14q32 region in hepatoblastoma "Hblast14"

PI: SANCHO BRU, PAU
Funding: Worldwide Cancer Research
Beneficiary organization: FRCB-IDIBAPS
Reference: 23-0356
Amount: 245,573.14 €
Duration: 01/04/2023 to 31/03/2026

Dissecting the cellular and molecular atlas of Rheumatoid Arthritis (RA) in sustained remission to identify pathways maintaining Remission and Triggering Flares

PI: CAÑETE CRESPILLO, JUAN DE DIOS
Funding: FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS
Beneficiary organization: FRCB-IDIBAPS
Reference: FOREUM_21_02
Amount: 90,000 €
Duration: 01/04/2023 to 31/03/2026

Decoding tanycytic mitochondrial dynamics in nutrient sensing and metabolic health.

PI: CLARET CARLES, MARC
Funding: EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES
Beneficiary organization: FRCB-IDIBAPS
Reference: EFSD/LILLY_23_01
Amount: 100,000 €
Duration: 01/07/2024 to 30/06/2026

ATLAX - Characterizing the signals from adipo-liver axis in NASH and unveiling their utility as disease biomarkers.

PI: GRAUPERA GARCIA MILA, ISABEL
Funding: PFIZER INC.
Beneficiary organization: FRCB-IDIBAPS
Reference: PFIZER_NASH_A_22_1
Amount: 127,775.17 €
Duration: 08/11/2023 to 30/06/2026

Mutimodal single cell profiling of tumor cell and microenvironment interactions driving clinical evolution and therapeutic responses in Mantle Cell Lymphoma

PI: CAMPO GUERRI, ELIAS
Funding: ASTRAZENECA UK LTD.
Beneficiary organization: FRCB-IDIBAPS
Reference: ASTRAZ_HEMAT_22_1
Amount: 647,255.72 €
Duration: 04/08/2022 to 03/08/2026

EHIN - Epithelioid Hemangioendothelioma International Network.

PI: RIMOLA GIBERT, JORDI
Funding: EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Beneficiary organization: FRCB-IDIBAPS
Reference: EASL_RG_21_01
Amount: 50,000 €
Duration: 01/09/2021 to 31/08/2026

Transcriptomic impact of blocking IL-5 with mepolizumab on CD4+T lymphocytes from patients with EGPA. Search for predictors of response

PI: ESPIGOL FRIGOLE, GEORGINA
Funding: Glaxosmithkline Research & Development Limited
Beneficiary organization: FRCB-IDIBAPS
Reference: 219739
Amount: 164,895.2 €
Duration: 08/09/2023 to 26/02/2027

MULTIlayer Predictive models for relapsed MCL after ibrutinib as first line therapY (MULTIPLY)

PI: BEA BOBET, SILVIA MARGARITA
Funding: Ludwig-Maximilians-Universitaet Muenchen
Beneficiary organization: FRCB-IDIBAPS
Reference: LLS_MCL_22_2
Amount: 221,720 €
Duration: 01/07/2023 to 30/06/2027

BioRTC Computational Neuroscience Course

PI: COMPTE BRAQUETS, ALBERT
Funding: Simons Foundation
Beneficiary organization: FRCB-IDIBAPS
Reference: 00009921
Amount: 71,009.28 €
Duration: 01/09/2024 to 31/08/2027

Unravelling the functional role and therapeutic potential of transcription factors in chronic lymphocytic leukemia

PI: MAIQUES DIAZ, ALBA
Funding: EHA (EUROPEAN HEMATOLOGY ASSOC.)
Beneficiary organization: FRCB-IDIBAPS
Reference: RG-202310-04245
Amount: 239,281 €
Duration: 01/09/2024 to 31/08/2027

CARTALLEU - Phase 2 clinical trial to evaluate the efficacy and safety of varnimcabtagene autoleucel for relapsed/refractory adult acute lymphoblastic leukaemia

PI: DELGADO GONZÁLEZ, JULIO
Funding: FUNDACIÓN CIENTIFICA ASOCIACIÓN ESPAÑOLA CONTRA EL CANCER
Beneficiary organization: FRCB-IDIBAPS
Reference: ATTRACT_23_01
Duration: 01/04/2024 to 31/03/2029

Structural heart disease training Fellowship

PI: FREIXA ROFASTES, XAVIER
Funding: EDWARDS LIFESCIENCES
Beneficiary organization: FRCB-IDIBAPS
Reference: EDWARDSFELLOW_24_01
Amount: 18,000 €
Duration: 23/07/2024 to 31/12/9998

DIGITALLY-ENHANCED PERSONALIZED MEDICINE: ACCURATE SELECTION OF SUBJECTIVE COGNITIVE DECLINE AND MEASURING PROGRESSION OF MILD COGNITIVE IMPAIRMENT

PI: BALASA, MIRCEA
Funding: ALTOIDA, INC.
Beneficiary organization: FRCB-IDIBAPS
Reference: ADDF_2019_01
Amount: 113,500 €
Duration: 01/08/2021 to 28/02/2024

ToIDC - Impact of autologous tolerogenic dendritic cells (ToIDC) on full mismatch kidney transplantation rat model

PI: VENTURA ABREU AGUIAR, PEDRO
Funding: PORTUGUESE TRANSPLANTATION SOCIETY
Beneficiary organization: FRCB-IDIBAPS
Reference: SPT_BAMPS_19_01
Amount: 10,000 €
Duration: 01/10/2021 to 31/03/2024

CRCNS US-Spanish Research Proposal: Circuit mechanisms of priors and learning during decision making

PI: POL SOROLLA, ALBERTO
Funding: Massachussets Institute of Technology
Beneficiary organization: FRCB-IDIBAPS
Reference: NSF_CRCNS_21_01
Amount: 0.01 €
Duration: 01/12/2022 to 30/11/2025

Modelling Age-related Macular Degeneration with a Blood-Retinal-Barrier Biomimetic System Combining Human Pluripotent Stem Cells and Decellularized Retinal Tissue

PI: MOLINS MONTEY, BLANCA
Funding: NOVARTIS FARMACÉUTICA, S.A
Beneficiary organization: FRCB-IDIBAPS
Reference: NOVARTIS_IIT_21_01
Amount: 37,000 €
Duration: 08/06/2022 to 31/08/2025

INTREPIBD - Identifying digital biomarkers of illNess activity and Treatment REsPonse In Bipolar Disorder .

PI: HIDALGO MAZZEI, DIEGO ALBERTO
Funding: Milken Institute. .
Beneficiary organization: FRCB-IDIBAPS
Reference: MILKEN_BD_21_01
Amount: 151,401.9 €
Duration: 10/12/2021 to 31/08/2024

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

PI: CAMPO GUERRI, ELIAS
Funding: Mayo Clinic Arizona
Beneficiary organization: FRCB-IDIBAPS
Reference: NIH_PAR-16-457_01
Amount: 837,653.95 €
Duration: 19/09/2018 to 30/06/2024

European Registry of patients treated with TIPS following a standardized, state of the art, pre, peri and post procedural approach: The EUROTIPS project

PI: RIMOLA GIBERT, JORDI PRAT APARICIO, ALEIX
Funding: EASL, European Association for Study of the Liver
Beneficiary organization: FRCB-IDIBAPS
Reference: EASL_RG_19_01
Amount: 40,000 €
Duration: 20/07/2020 to 19/07/2024

Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes

PI: BEA BOBET, SILVIA MARGARITA
Funding: Ludwig-Maximilians-Universitaet Muenchen
Beneficiary organization: FRCB-IDIBAPS
Reference: LMUM_EMCLP_21_01
Amount: 5,000 €
Duration: 29/04/2022 to 28/04/2024

Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptonic footprints

PI: CAMPO GUERRI, ELIAS
Funding: EHA (EUROPEAN HEMATOLOGY ASSOC.)
Beneficiary organization: FRCB-IDIBAPS
Reference: RG-202012-00245
Amount: 150,000 €
Duration: 01/01/2022 to 31/12/2024

Molecular characterization of obesity/diabetes/NASH-related hepatocellular carcinoma

PI: LLOVET BAYER, JOSEP MARIA
Funding: EASL, European Association for Study of the Liver
Beneficiary organization: FRCB-IDIBAPS
Reference: EASL_JR_12_20
Amount: 120,000 €
Duration: 01/05/2021 to 30/04/2024

The Edmond J. Safra Fellowship in Movement Disorders - Hospital Clinic Barcelona

PI: CAMPO GUERRI, ELIAS & VALLDEORIOLA SERRA, FRANCESC
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: FRCB-IDIBAPS
Reference: MJFF-023487
Amount: 170,928 €
Duration: 01/09/2023 to 31/08/2026

BLOOD a-SYNUCLEIN AGGREGATION ASSAY AS A NOVEL DIAGNOSTIC TOOL FOR PARKINSON’S DISEASE

PI: FERNANDEZ SANTIAGO, RUBEN & COMPTA HIRNYJ, YAROSLAU
Funding: US Department of Defence
Beneficiary organization: FRCB-IDIBAPS
Reference: DOD_PRP_23_01
Amount: 328,679.43 €
Duration: 01/09/2024 to 31/08/2026

Interaction between MRI metrics and biomarkers of chronic activity to predict disability outcomes and treatment response in multiple sclerosis

PI: LLUFRIU DURAN, SARA
Funding: Congrex Switzerland Ltd,
Beneficiary organization: FRCB-IDIBAPS
Reference: ECTRIMS_FELLOW21_02
Amount: 110,000 €
Duration: 01/11/2022 to 31/10/2024

RICHARDIII - A pilot study on the use of ARI-0003 cells (dual anti-CD19/CD9 chimeric antigen receptor T-cells) for patients with relapsed/refractory Richter's transformation

PI: DELGADO GONZÁLEZ, JULIO
Funding: Cancer Research Institute
Beneficiary organization: FRCB-IDIBAPS
Reference: INT_CRI_CIG_23_01
Amount: 942,595.99 €
Duration: 01/01/2025 to 31/12/2027

PREDICTION OF TREATMENT NEEDS USING A HYBRID ARTIFICIAL INTELLIGENCE-BASED MANAGEMENT ASSISTANT (ALMA) TOOL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

PI: ZARRANZ VENTURA, JAVIER
Funding: Foundation of the Society of Retina Specialists
Beneficiary organization: FRCB-IDIBAPS
Reference: EURETINA_24_1
Amount: 227,503 €
Duration: 01/06/2025 to 31/05/2027

Single cell subclonal characterization and evolution of the genome and transcriptome in IgM monoclonal gammopathy

PI: MORENO FAJARDO, DAVID FERNANDO
Funding: International Waldenstrom's Macroglobulinemia Foundation
Beneficiary organization: FRCB-IDIBAPS
Reference: IWMF_KCDA_24_01
Amount: 146,603.01 €
Duration: 17/02/2025 to 16/02/2027

Enabling Artificial Intelligence (AI) for Early Detection of Melanoma in Smartphone Images

PI: MALVEHY GUILERA, JOSE
Funding: SLOAN KETTERING INSTITUTE FOR CANCER RES
Beneficiary organization: FRCB-IDIBAPS
Reference: MRA_TSA_24_01
Amount: 72,285 €
Duration: 01/06/2024 to 31/05/2027

Cognitive Neuroscience of Attention and Working Memory in Schizophrenia

PI: COMPTE BRAQUETS, ALBERT
Funding: UNIVERSITY OF MARYLAND
Beneficiary organization: FRCB-IDIBAPS
Reference: R01MH065034_01
Amount: 28,010.77 €
Duration: 15/08/2024 to 30/06/2029

Unravelling the molecular heterogeneity of CD23+-BCL2R- follicle center lymphomas

PI: CAMPO GUERRI, ELIAS
Funding: European Association for Haematopatholog
Beneficiary organization: FRCB-IDIBAPS
Reference: EA4HP_DYM_24_01
Amount: 7,128.01 €
Duration: 01/11/2024 to 31/10/2025